GOHEALTH MD INC
NTN 10Q, 2000-11-14
COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
Previous: VARIABLE INSURANCE PRODUCTS FUND, 13F-NT, 2000-11-14
Next: DENTAL RESOURCES INC, DEF 14A, 2000-11-14



                           UNITED  STATES                 SEC File Number
                 SECURITIES  AND EXCHANGE COMMISSION      0-10201
                      Washington, D.C. 20549
                              -------
                                                       CUSIP Number
                           FORM 12b-25                 669903304
                   NOTIFICATION OF LATE FILING
(Check One)
          [ ] Form 10-K [ ]Form 20-F [ ]Form 11-K [X]Form 10-Q  [ ]Form N-SAR
               For Period Ended: September 30, 2000
          [ ] Transition Report on Form 10-K
          [ ] Transition Report on Form 20-F
          [ ] Transition Report on Form 11-K
          [ ] Transition Report on Form 10-QSB
          [ ] Transition Report on Form N-SAR
               For the Transition Period Ended:

READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE
Nothing in the form shall be construed to imply that the Commission
has verified any information contained herein.
If  the  notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:


                  PART I - REGISTRANT INFORMATION

GoHealth.MD, Inc.
Full Name of Registrant

Nugget Exploration, Inc.
Former Name if Applicable

2051 Springdale Road
Address of Principal Executive Office (Street and Number)

Cherry Hill, NJ 08003
City, State and Zip Code


                       PART II - RULES 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to  Rule 12b-25(b),  the following
should be completed.  (Check  appropriate box)

[ ] a)  The reasons described in reasonable detail in Part III of this  form
could not be eliminated without unreasonable effort  or expense;

[X] (b) The subject annual report, semi-annual report, transition report  on
Form  10-K,  Form 20-F, 11-K, Form  N-SAR,  or  portion thereof,  will  be
filed on or before the fifteenth  calendar  day following the prescribed due
date; or the subject quarterly  report or transition report on Form 10-Q, or
portion thereof will be filed on  or  before the fifth calendar day following
the prescribed  due date; and

[ ] (c) The accountant's statement or other exhibit required  by Rule 12b-25(c)
has been attached if applicable.

                       PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11- K,  10-Q,
N-SAR, or the transition report or portion thereof, could not  be  filed within
the prescribed time period.   (Attach  Extra Sheets if Needed)

      During the third quarter ended September 30, 2000, we entered into a
merger agreement for a significant transaction, which was subsequently
abandoned after the end of the quarter. This transaction, before it was
abandoned, required extensive time commitments from our executives and
accountants. These time commitments delayed the completion of the financial
statenments for the quarter ended September 30, 2000.

                          PART IV - OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
notification

Dr. Leonard Vernon        President           (800) 204-1902)
   (Name)                   (Title)            (Telephone Number)

(2)   Have all other periodic reports required under Section 13  or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of  the Investment  Company
Act of 1940 during the preceding 12  months  or for  such shorter period that
the registrant was required to file such report(s) been filed? If the answer is
no,  identify report(s).     [X] Yes   [ ] No

(3)   Is  it anticipated that any significant change in results  of operations
from the corresponding period for the last fiscal  year will be reflected by
the earnings statements to be included in  the subject report or portion
thereof?  [x] Yes   [ ] No

      If  so, attach an explanation of the anticipated change, both narratively
and  quantitatively, and, if  appropriate,  state  the reasons why a reasonable
estimate of the results cannot be made:

  We effected a reverse merger transaction with GoHealth.MD., Inc., a Delaware
corporation, on November 10, 1999. In November 1999 we changed the principal
focus of our business strategy from registering and marketing tradenames to
operating healthcare websites. Therefore, the results of operations for the
quarter ended September 30, 2000 will be signifignatly different from those in
the corresponding period of the 1999 fiscal. The quartley results will be
similar to the results of operations for the quarter ended June 30, 2000.


                               GoHealth.MD, Inc.
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date         November 13, 2000.         By /s/ Dr. Leonard Vernon
                                                   Leonard Vernon
                                                   President



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission